Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Carbapenemase-Producing Enterobacteriaceae (CPE) Bloodstream Infections (BSI) in Neutropenic Patients (pts) with Acute Leukemia (AL). Comparison of 2 Strategies

Marcos Lemos, MD, Rebeca Brito, MD, Margarida Fevereiro, MD, Mariana L. Fernandes, MD, Filipa Saraiva, MD, Susana G Pereira, MD, Leonor Sarmento, MD, Alexandra Monteiro, MD, Aida B Sousa, MD

Blood (2019) 134 (Supplement_1): 1333.

https://doi.org/10.1182/blood-2019-124986

Published: 2019

Journal Articles

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

Alejandra Ortiz-Ruiz, BSc, Yanira Ruiz-Heredia, Mehmet Samur, PhD, Pedro Aguilar-Garrido, Maria Luz Morales, Antonio Valeri, PhD, Almudena Garcia-Ortiz, PhD, Santiago Barrio, PhD, Carmen Bárcena, Rosa Maria Garcia-Martin, Vanesa Garrido, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD, María Teresa Cedena, Joaquin Martinez-Lopez, MD PhD, Maria Linares, PhD, Miguel Gallardo, PhD

Blood (2019) 134 (Supplement_1): 4408.

https://doi.org/10.1182/blood-2019-123950

Published: 2019

Journal Articles

Combination of Tigecycline and Homoharringtonine Synergistically Enhances Anti-Leukemia and Anti-MDS Effect Followed By Inhibiting Mitochondrial Translation through AKT/Mtorpathway and Downregulation of Anti-Apoptotic Proteins

Jie Jin, MD PhD, Hongyan Tong, Yang Haiyang

Blood (2019) 134 (Supplement_1): 5387.

https://doi.org/10.1182/blood-2019-128171

Published: 2019

Journal Articles

Combination of Four Drugs for Bloodstream Infection Caused By Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients after Hematopoietic Stem Cell Transplantation

Yaqun Hong, Xiaofan Li, MD PhD, Xianling Chen, MS, Ping Chen, MD, Meiling Chen, MS, Yiting Wang, MS, Zhenshu Xu, MD, Nainong Li, MD PhD

Blood (2019) 134 (Supplement_1): 5664.

https://doi.org/10.1182/blood-2019-128257

Published: 2019

Journal Articles

The Long Noncoding RNA BALR2 Controls Novel Transcriptional Circuits Involved in Chemotherapy Sensitivity of Pediatric Acute Myeloid Leukemia (AML) Blasts

Valeria Bisio, PhD, Maddalena Benetton, Elena Porcù, PhD, Matteo Bordi, PhD, Carlo Zanon, PhD, Giulia Borella, Ambra Da Ros, Giuseppe Germano, PhD, Sabrina Manni, PhD, Claudia Tregnago, PhD, Silvia Campello, PhD, Dinesh S. Rao, MD PhD, Franco Locatelli, MD PhD, Martina Pigazzi, PhD

Blood (2019) 134 (Supplement_1): 2734.

https://doi.org/10.1182/blood-2019-128152

Published: 2019

Journal Articles

Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia

Ran Zhao, BS, Sarah Zarabi, MD, Takenobu Nii, PhD, Ondrej Halgas, PhD, Yulia Jitkova, PhD, Vivian Ruvolo, Lauren Heese, Yuki Nishida, MD PhD, Gautam M. Borthakur, MD, Kensuke Kojima, MD PhD, Martin Stogniew, Wolfgang Oster, MD, Emil Pai, PhD, Eric Davis, MD, Hagop M. Kantarjian, MD, Aaron D Schimmer, MD PhD, Michael Andreeff, MD PhD, Jo Ishizawa, MD PhD

Blood (2019) 134 (Supplement_1): 2562.

https://doi.org/10.1182/blood-2019-127101

Published: 2019

Journal Articles

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Tingting Yang, Xueping Luo, MD, Qing Yang, MD, Hongchao Chen, Yi Luo, MD, Yanmin Zhao, MD, Xiaoyu Lai, MD, Jian Yu, MD, Yamin Tan, MD, Guoqing Wei, MD, He Huang, Jimin Shi, MD

Blood (2019) 134 (Supplement_1): 5606.

https://doi.org/10.1182/blood-2019-127599

Published: 2019

Journal Articles

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Hemanth Kumar, MBBS, MD, Nikita Mehra, MD DM, Prasanth Ganesan, MD DM, Venkatraman Radhakrishnan, MD DM, Manikandan Dhanushkodi, MD DM, Jayachandran P K, MD DM, Trivadi S Ganesan, MD DM, S Krupa Shankar, MD DM, Tenali Gnana Sagar, MD DM, Krishnarathinam Kannan, MD DM

Blood (2018) 132 (Supplement 1): 4008.

https://doi.org/10.1182/blood-2018-99-119919

Published: 2018

Journal Articles

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Liat Shargian-Alon, MD, Anat Gafter-Gvili, Ofir Wolach, MD, Moshe Yeshurun, Pia Raanani, Dafna Yahav, MD

Blood (2018) 132 (Supplement 1): 4953.

https://doi.org/10.1182/blood-2018-99-114165

Published: 2018

Journal Articles

Hematologic Malignancies and Carbapenem Resistance: A Multicentre Retrospective Study from Chinese People

Bing Xu, MD PhD, Suming Huang, PhD, Lingli He, Guoshu Chen, Zhifeng Li, Pengcheng Shi, Xutao Guo, Zhihong Fang, Yan Wang, Jie Li, Yong Zhou

Blood (2017) 130 (Supplement 1): 4826.

https://doi.org/10.1182/blood.V130.Suppl_1.4826.4826

Published: 2017

Journal Articles

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

Davinder Paul, MD, Anant Ganesh Gokarn, MD DM, Vasudev Bhat, MD, Vivek Bhat, MD, Avinash Bonda, MD, Saurabh Zanwar, MD, Libin Mathew, Sadhana Kannan, Deepa Susan, MD DM, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2016) 128 (22): 3389.

https://doi.org/10.1182/blood.V128.22.3389.3389

Published: 2016

Journal Articles

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Pugliese Novella, Paola Salvatore, MD, Dora Vita Iula, MD, Maria Rosaria Catania, MD, Federico Chiurazzi, MD, Marta Raimondo, Giuliana Beneduce, Claudio Cerchione, Roberta Della Pepa, Claudia Giordano, MD, Luigia Simeone, MD, Fabrizio Pane, MD, Marco Picardi

Blood (2016) 128 (22): 3550.

https://doi.org/10.1182/blood.V128.22.3550.3550

Published: 2016

Journal Articles

Therapy Resistant CML Stem Cells Are Dependent on Mitochondrial Oxidative Metabolism for Their Survival

Elodie Marie Kuntz, Pablo Baquero, PhD, Tessa L. Holyoake, MD PhD FRCP, FRCPath, Eyal Gottlieb, PhD, G. Vignir Helgason, PhD

Blood (2016) 128 (22): 932.

https://doi.org/10.1182/blood.V128.22.932.932

Published: 2016

Journal Articles

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Ting Niu, MD PhD, Lung-Ji Chang, PhD, Jinrong Yang, MD, Yuchen Liu, MSc, Lujia Dong, MD, Wei Wang, PhD, Ting Liu, MD

Blood (2015) 126 (23): 5431.

https://doi.org/10.1182/blood.V126.23.5431.5431

Published: 2015

Journal Articles

Tigecycline Was a Promising Candidate for Febrile Neutropenic and Carbapenem-Resistant Patients with Hematologic Malignancy

Bing Xu, PhD, Lingli He, Pengcheng Shi, Xutao Guo, Jie Li, Yan Wang, Manman Deng, Yong Zhou, Yin Li, Jiabao Liang

Blood (2015) 126 (23): 4610.

https://doi.org/10.1182/blood.V126.23.4610.4610

Published: 2015

Journal Articles

Isocitrate Dehydrogenase Mutations Induce BCL-2 Dependence in Acute Myeloid Leukemia through Inhibition of Cytochrome C Oxidase Function

Steven M. Chan, MD PhD, Daniel Thomas, MD PhD, Bruno C Medeiros, MD, Ravindra Majeti, MD PhD

Blood (2014) 124 (21): 615.

https://doi.org/10.1182/blood.V124.21.615.615

Published: 2014

Journal Articles

Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML

Jhas Bozhena, BSc, Shrivani Sriskanthadevan, PhD, Marko Skrtic, PhD, Mahadeo A. Sukhai, PhD, Veronique Voisin, PhD, Yulia Jitkova, PhD, Marcela Gronda, MSc, Rose Hurren, BSc, Xiaoming Wang, Rob C. Laister, PhD, Gary D. Bader, Ph.D., Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD

Blood (2012) 120 (21): 1364.

https://doi.org/10.1182/blood.V120.21.1364.1364

Published: 2012

Journal Articles

Inhibition of Mitochondrial Translation As a Therapeutic Strategy for Acute Myeloid Leukemia (AML)

Blood (2011) 118 (21): 233.

https://doi.org/10.1182/blood.V118.21.233.233

Published: 2011

Journal Articles

AML Cells Have Increased Mitochondrial Mass but Less Reserve in Their Respiratory Chain Complexes Leading to Heightened Sensitivity to Inhibition of Mitochondrial Protein Translation,

Shrivani Sriskanthadevan, PhD, Skrtic Marko, BSc, Bozhena Livak, BSc, Yulia Jitkova, PhD, Rose Hurren, BSc, Marcela Gronda, MSc, Rob Laister, PhD, Peter Mullen, PhD, Linda Penn, PhD, Mark D. Minden, MD, PhD, Aaron D Schimmer, MD, PhD

Blood (2011) 118 (21): 3585.

https://doi.org/10.1182/blood.V118.21.3585.3585

Published: 2011

NARROW

Carbapenemase-Producing Enterobacteriaceae (CPE) Bloodstream Infections (BSI) in Neutropenic Patients (pts) with Acute Leukemia (AL). Comparison of 2 Strategies

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

Combination of Tigecycline and Homoharringtonine Synergistically Enhances Anti-Leukemia and Anti-MDS Effect Followed By Inhibiting Mitochondrial Translation through AKT/Mtorpathway and Downregulation of Anti-Apoptotic Proteins

Combination of Four Drugs for Bloodstream Infection Caused By Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients after Hematopoietic Stem Cell Transplantation

The Long Noncoding RNA BALR2 Controls Novel Transcriptional Circuits Involved in Chemotherapy Sensitivity of Pediatric Acute Myeloid Leukemia (AML) Blasts

Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Hematologic Malignancies and Carbapenem Resistance: A Multicentre Retrospective Study from Chinese People

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Therapy Resistant CML Stem Cells Are Dependent on Mitochondrial Oxidative Metabolism for Their Survival

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Tigecycline Was a Promising Candidate for Febrile Neutropenic and Carbapenem-Resistant Patients with Hematologic Malignancy

Isocitrate Dehydrogenase Mutations Induce BCL-2 Dependence in Acute Myeloid Leukemia through Inhibition of Cytochrome C Oxidase Function

Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML

Inhibition of Mitochondrial Translation As a Therapeutic Strategy for Acute Myeloid Leukemia (AML)

AML Cells Have Increased Mitochondrial Mass but Less Reserve in Their Respiratory Chain Complexes Leading to Heightened Sensitivity to Inhibition of Mitochondrial Protein Translation,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only